The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Parrish Jay since 2020.
This trader's CIK number is 1786372.
At the time of last reporting, Parrish Jay was the Chief Business Officer of Vir Biotechnology, Inc.. (stock ticker symbol VIR).
Also see all insider trading activities at Vir Biotechnology, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | VIR | 0 | $0 | 27,777 | $1,465,709 | 27,777 | $42,185 |
| 2020 | VIR | 0 | $0 | 263,887 | $9,220,307 | 263,887 | $397,307 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-04-01 | VIR | Option Ex | 6,944 | 1.53 | 10,624 |
| 2021-04-01 | VIR | Sale | 6,944 | 51.41 | 356,956 |
| 2021-03-01 | VIR | Sale | 6,944 | 63.44 | 440,534 |
| 2021-03-01 | VIR | Option Ex | 6,944 | 1.53 | 10,624 |
| 2021-02-01 | VIR | Option Ex | 6,944 | 1.53 | 10,624 |
| 2021-02-01 | VIR | Sale | 6,944 | 69.91 | 485,427 |
| 2021-01-04 | VIR | Sale | 6,945 | 26.32 | 182,792 |
| 2021-01-04 | VIR | Option Ex | 6,945 | 1.49 | 10,313 |
| 2020-12-01 | VIR | Option Ex | 6,945 | 1.53 | 10,625 |
| 2020-12-01 | VIR | Sale | 6,945 | 31.53 | 218,968 |
| 2020-11-02 | VIR | Option Ex | 6,944 | 1.53 | 10,624 |
| 2020-11-02 | VIR | Sale | 6,944 | 31.27 | 217,152 |
| 2020-10-01 | VIR | Sale | 6,945 | 34.75 | 241,338 |
| 2020-10-01 | VIR | Option Ex | 6,945 | 1.53 | 10,625 |
| 2020-09-01 | VIR | Sale | 6,943 | 39.15 | 271,797 |
| 2020-09-01 | VIR | Option Ex | 6,943 | 1.57 | 10,935 |
| 2020-08-03 | VIR | Sale | 11,110 | 47.65 | 529,402 |
| 2020-08-03 | VIR | Option Ex | 11,110 | 1.53 | 16,998 |
| 2020-07-01 | VIR | Sale | 75,000 | 37.95 | 2,846,325 |
| 2020-07-01 | VIR | Option Ex | 75,000 | 1.53 | 114,750 |
| 2020-06-01 | VIR | Option Ex | 75,000 | 1.49 | 111,375 |
| 2020-06-01 | VIR | Sale | 75,000 | 35.22 | 2,641,425 |
| 2020-05-14 | VIR | Sale | 75,000 | 30.05 | 2,253,900 |
| 2020-05-14 | VIR | Option Ex | 75,000 | 1.49 | 111,375 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Parrish Jay (Chief Business Officer of Vir Biotechnology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.